Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $57.75 million. The enterprise value is $69.55 million.
| Market Cap | 57.75M |
| Enterprise Value | 69.55M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 30.00 million shares outstanding. The number of shares has increased by 5.13% in one year.
| Shares Outstanding | 30.00M |
| Shares Change (YoY) | +5.13% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 6.59% |
| Owned by Institutions (%) | 65.84% |
| Float | 20.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| Forward PS | 0.70 |
| PB Ratio | 2.09 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.65, with a Debt / Equity ratio of 2.26.
| Current Ratio | 5.65 |
| Quick Ratio | 4.70 |
| Debt / Equity | 2.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.59 |
Financial Efficiency
Return on equity (ROE) is -75.80% and return on invested capital (ROIC) is -30.52%.
| Return on Equity (ROE) | -75.80% |
| Return on Assets (ROA) | -26.70% |
| Return on Capital (ROIC) | -30.52% |
| Revenue Per Employee | $360,714 |
| Profits Per Employee | -$135,675 |
| Employee Count | 203 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.75% in the last 52 weeks. The beta is 2.32, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 2.32 |
| 52-Week Price Change | -3.75% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 2.60 |
| Relative Strength Index (RSI) | 48.21 |
| Average Volume (20 Days) | 123,232 |
Short Selling Information
The latest short interest is 119,111, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 119,111 |
| Short Previous Month | 90,538 |
| Short % of Shares Out | 0.40% |
| Short % of Float | 0.59% |
| Short Ratio (days to cover) | 0.77 |
Income Statement
In the last 12 months, Neuronetics had revenue of $73.23 million and -$27.54 million in losses. Loss per share was -$0.95.
| Revenue | 73.23M |
| Gross Profit | 53.40M |
| Operating Income | -27.51M |
| Pretax Income | -27.54M |
| Net Income | -27.54M |
| EBITDA | -19.49M |
| EBIT | -21.54M |
| Loss Per Share | -$0.95 |
Balance Sheet
The company has $50.67 million in cash and $62.47 million in debt, giving a net cash position of -$11.81 million or -$0.39 per share.
| Cash & Cash Equivalents | 50.67M |
| Total Debt | 62.47M |
| Net Cash | -11.81M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 27.66M |
| Book Value Per Share | 0.92 |
| Working Capital | 67.37M |
Cash Flow
In the last 12 months, operating cash flow was -$28.84 million and capital expenditures -$2.51 million, giving a free cash flow of -$31.35 million.
| Operating Cash Flow | -28.84M |
| Capital Expenditures | -2.51M |
| Free Cash Flow | -31.35M |
| FCF Per Share | -$1.06 |
Margins
Gross margin is 72.92%, with operating and profit margins of -37.56% and -37.61%.
| Gross Margin | 72.92% |
| Operating Margin | -37.56% |
| Pretax Margin | -37.61% |
| Profit Margin | -37.61% |
| EBITDA Margin | -26.62% |
| EBIT Margin | -29.42% |
| FCF Margin | -42.81% |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.13% |
| Shareholder Yield | -5.13% |
| Earnings Yield | -47.70% |
| FCF Yield | -54.29% |
Analyst Forecast
The average price target for Neuronetics is $8.00, which is 315.58% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 315.58% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 16.58% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.92 |
| Piotroski F-Score | 2 |